Renal Impairment Has No Relevant Effect on Long-Term Exposure of Linagliptin in Patients with Type 2 Diabetes Mellitus

被引:0
|
作者
Friedrich, Christian
Emser, Angela
Woerle, Hans J.
Graefe-Mody, Ulrike
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1105-P
引用
收藏
页码:A303 / A304
页数:2
相关论文
共 50 条
  • [41] The effect of long-term past glycemic control on executive function among patients with type 2 diabetes mellitus
    Taichi Minami
    Yuzuru Ito
    Masayo Yamada
    Ryutaro Furuta
    Fuyuki Minagawa
    Kentaro Kamata
    Akiko Kameda
    Yasuo Terauchi
    Diabetology International, 2020, 11 : 114 - 120
  • [42] Linagliptin: An Update of Its Use in Patients with Type 2 Diabetes Mellitus
    Kate McKeage
    Drugs, 2014, 74 : 1927 - 1946
  • [43] Linagliptin: An Update of Its Use in Patients with Type 2 Diabetes Mellitus
    McKeage, Kate
    DRUGS, 2014, 74 (16) : 1927 - 1946
  • [44] Linagliptin versus placebo followed by glimepiride in type 2 diabetes patients with moderate to severe renal impairment
    Groop, P. -H.
    Laakso, M.
    Rosenstock, J.
    Hehnke, U.
    Tamminen, I.
    Patel, S.
    von Eynatten, M.
    Woerle, H. -J.
    DIABETOLOGIA, 2013, 56 : S364 - S365
  • [45] Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes
    Fineberg, SE
    Huang, J
    Brunelle, R
    Gulliya, KS
    Anderson, JH
    DIABETES CARE, 2003, 26 (01) : 89 - 96
  • [46] Linagliptin added to sulphonylurea in uncontrolled type 2 diabetes patients with moderate-to-severe renal impairment
    McGill, Janet B.
    Barnett, Anthony H.
    Lewin, Andrew J.
    Patel, Sanjay
    Neubacher, Dietmar
    von Eynatten, Maximilian
    Woerle, Hans-Juergen
    DIABETES & VASCULAR DISEASE RESEARCH, 2014, 11 (01): : 34 - 40
  • [47] Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
    Silke Retlich
    Vincent Duval
    Ulrike Graefe-Mody
    Christian Friedrich
    Sanjay Patel
    Ulrich Jaehde
    Alexander Staab
    Clinical Pharmacokinetics, 2015, 54 : 737 - 750
  • [48] Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
    Retlich, Silke
    Duval, Vincent
    Graefe-Mody, Ulrike
    Friedrich, Christian
    Patel, Sanjay
    Jaehde, Ulrich
    Staab, Alexander
    CLINICAL PHARMACOKINETICS, 2015, 54 (07) : 737 - 750
  • [49] Efficacy and Safety of Linagliptin as Add-on to Basal Insulin in Patients with Type 2 Diabetes and Renal Impairment
    Mcgill, Janet B.
    Yki-Jarvinen, Hannele
    Duran-Garcia, Santiago
    Thiemann, Sandra
    Hehnke, Uwe
    Pinnetti, Sabine
    Patel, Sanjay
    Woerle, Hansjuergen
    DIABETES, 2014, 63 : A264 - A264
  • [50] Factors Associated with Long-Term Control of Type 2 Diabetes Mellitus
    Badedi, Mohammed
    Solan, Yahiya
    Darraj, Hussain
    Sabai, Abdullah
    Mahfouz, Mohamed
    Alamodi, Saleh
    Alsabaani, Abdullah
    JOURNAL OF DIABETES RESEARCH, 2016, 2016